The Wilms' tumour suppressor, WT1, is a zinc finger protein with key roles in normal development of the genitourinary system and tumourigenesis. Mutations or deletion of WT1 result in a spectrum of developmental disorders and susceptibility to Wilms' tumour in children. Ectopic expression of Wt1 associated with oncogenic functions has been observed in a large number of malignancies, including haematological and solid cancers. Although Wt1 is predominantly a nuclear protein in normal tissues, it is mostly cytoplasmic in the majority of Wt1-expressing tumours. Actin was identified in this study as a new WT1 interaction partner both in the nucleus and in the cytoplasm. We confirmed this interaction both in vitro and in vivo and started to explore its functional significance. Perturbation of the actin cytoskeleton moved Wt1 off the polysome fraction in the cytoplasm, cancelled its nucleo-cytoplasmic shuttling and altered Wt1 DNAand RNA-binding abilities. These data have implications for Wt1 functions in relation to RNA metabolism and response to cytoskeletal alterations in cancer cells. Thus, our findings could shed more light on the functions of both these proteins and possibly pave way for the development of new cancer therapies.
WT1 was first described as a tumour-suppressor gene associated with childhood nephroblastoma; however, it was later hypothesized that WT1 could have an oncogenic function in many kinds of adult cancers. It is highly expressed in leukaemias and solid cancers, including breast and lung cancers, gliomas and oligodendrogliomas (Nakatsuka et al., 2006) . WT1 is a multifunctional zinc finger protein mainly known as a transcription factor essential for the development of a number of mesodermally derived tissues (Hohenstein and Hastie, 2006) . In the cell, Wt1 is localized predominantly in the nucleus, with B10% of the protein found in the cytoplasm. In adult malignancies, it is mostly cytoplasmic (Nakatsuka et al., 2006; Bing et al., 2008) ; thus, the search for Wt1 cytoplasmic interactions has taken on greater importance. We found actin to be a new protein partner of Wt1 both in the nucleus and in the cytoplasm. Actin is predominantly a cytoplasmic protein; however, up to 10% of the protein can be found in association with the nucleus. Nuclear actin is implicated in transcription by all three RNA polymerases, chromatin remodelling and export of some RNAs (de Lanerolle et al., 2005, Louvet and Percipalle, 2009 ). Cytoplasmic actin, as the major component of the cytoskeleton, is not only pivotal for the maintenance of cell morphology, movement and cell division but is also essential for the regulation of RNA stability, transport and RNA translation (Jansen, 1999) . Notably perturbation of the actin cytoskeleton is essential for malignant transformation. Wt1 is also reported to be implicated in RNA metabolism: it was shown to shuttle between the nucleus and cytoplasm (Niksic et al., 2004) , was found in splicing complexes in the nucleus (Davies et al., 1998) and on polysomes in the cytoplasm. However, the functional significance of these findings remains unclear. Identification of proteins involved in the same interactions could shed more light on the multiple functions of Wt1.
To identify novel WT1 interacting proteins, we used the experimental approach of co-immunoprecipitating (IP) endogenous proteins and further identification of candidates using MALDI-TOF (matrix-assisted laser desorption/ionization-time of flight) analysis. The rabbit polyclonal anti-WT1 antibody, C-19, was used to immunopreciptate WT1 complexes from cell extracts derived from wild-type and Wt1-depleted embryonic stem cells (Spraggon et al., 2007) differentiated for 96 h with all-trans retinoic acid. Protein bands specific to wild-type embryonic stem cell C19 pull downs were subjected to MALDI-TOF analysis. One of the precipitated proteins showed high similarity to either b-or g-actin (Spraggon et al., 2007) . We repeated WT1 IPs as described above, and actin was identified in the immunoprecipitates by western blot analysis ( Figure 1a , lane 2). As a control, actin was not precipitated with IgG (lane 1) or with an irrelevant antibody (HA antibody, data not shown), or from cell extracts lacking WT1 (Figure 1a, lane 3) , thus confirming the specificity of the IP and interaction. We performed reciprocal precipitation of actin-binding complexes with DNAseI sepharose that specifically binds actin (data not shown) and confirmed the co-precipitation of Wt1. All-trans retinoic acid-treated embryonic stem cells represent a heterogeneous population of cells with different differentiation potentials. To address tissue-specific aspects of the interaction, we performed immunoprecipitations for WT1 and actin using extracts from a mouse mesonephric kidney cell line M15 (Ladomery et al., 1999) and rat- -4, 11-15) or corresponding dilution of DMSO (lanes 5-10). The cytoplasmic fraction (cy) was obtained from cells extracted with the hypotonic buffer (10 mM Tris-HCl pH 7.4, 10 mM NaCl, 0.4% NP-40, 3 mM MgCl 2 , protease inhibitor cocktail (Roche Diagnostics)). Subsequent extraction with lysis buffer (as in panel a) produced a nuclear extract (nu). The extracts were denatured with 8 M urea (lanes 3-4, 7-8 and 12-13), diluted 1:10 in IP buffer (as in panel a) and used for Wt1 IP with C19 anti-Wt1 antibody (lanes 1-8)/rabbit IgG (lanes 9-10, control) or for actin precipitation (lanes 11-15) with DNAseI sepharose (lanes 12-15)/BSA-sephrose (lane 11, control). After extensive washes in RIPA buffer (20 mM Tris pH7.6, 120 mM NaCl, 0.01% SDS, 0.01% deoxycholate, 0.4% NP-40, protease inhibitor cocktail (Sigma-Aldrich)) of protein-G sepharose precipitates cross-linker was cleaved by boiling. The samples were analysed by western blot using anti-Wt1 and anti-b-actin antibodies. (c) GST pull down assays. GST-WT1 deletion mutants (lanes 1-4) and GST-Kaiso protein (lanes 5-6) and GST only (lanes 7-8), expressed in Escherichia Coli and purified (as described in Lee et al., 1999) on beads were incubated with monomeric actin (Sigma-Aldrich) in binding buffer BB (50 mM Tris-HCl (pH 7.5), 12.5 mM MgCl 2 , 10% glycerol, 1% NP-40, 150 mM NaCl, 1 mM DTT, 200 mg/ml bovine serum albumin) for 1 h at 4 1C; and subsequently washed in BB. The bound (b) fraction and unbound (u) proteins were processed for western blot analysis. Actin could directly bind WT1 through WT1 zinc fingers in vitro (lanes 3-4). The scheme of the protein constructs used is shown on the bottom panel of c. immortalized epicardial cells, both expressing high levels of endogenous WT1 ( Figure 1a , lanes 6-8 and 9-10). Wt1 actin co-precipitation was observed in both cases. In all immunoprecipitations, extracts were treated with both DNase and RNase, suggesting that the interaction was not mediated by nucleic acid. The presence of the interaction regardless of the cell type points to its general nature and stresses its potential importance in regulating Wt1 functions.
To confirm direct interaction of the proteins in vivo we used the short-range cleavable cross-linker DSP (dithiobissuccinimidylpropionate) (Sigma-Aldrich) in the standard cultivation medium. Cross-linked M15 nuclear and cytoplasmic extracts were denatured with urea to abolish indirect and non-specific interactions. Diluted denatured and non-denatured extracts were used for Wt1 IP (Figure 1b ). Actin was detected by immunoblotting in urea-treated Wt1 IP precipitates extracted from cross-linked cells ( Figure 1b , lanes 3-4) and was removed by urea denaturation in native extracts (Figure 1b, . The reciprocal experiment of precipitation of actin containing complexes with DNAse I in similar conditions also showed Wt1 to be an actinbinding partner (Figure 1b, lanes 11-15) . These results indicate the direct binding of Wt1 and actin in vivo.
To determine the domains of WT1 involved in the interaction with actin, we performed in vitro pull-down assays. We tested the actin-binding ability of bacterially expressed and purified glutathione-S-transferase (GST)-WT1 full-length protein, including exon 5, but lacking the KTS insert (amino acids 1-446) and deletion mutants, including GST-WT1 zinc fingers, (-KTS) (amino acids 297-446) and GST-WT1-N-terminus (amino acids 1-242). Unfortunately, it was very difficult to solubilize fulllength Wt1; hence, we conducted most of our experiments with Wt1 deletion mutants. From the GST-binding assays, we conclude that actin can directly interact with Wt1 and that the association is mediated through the zinc fingers of Wt1 (Figure 1c, lanes 3-4) , and not through the N terminus (lanes 1-2). The full-length Wt1 could also bind actin (data not shown). The specificity of this in vitro interaction was confirmed by the observation that the GST-tagged Kaiso protein, also featuring zinc fingers in its structure, does not interact with actin ( Figure 1c , lanes 5-6) in the same assay.
To confirm that Wt1 interacts with actin through its zinc finger domain in live cells, HeLa cells were transfected with Wt1 constructs described in the study by Ladomery et al. (1999) . The cells were treated with DSP, and IPs were carried out as described above. The presence of the KTS insert or exon 5 did not alter Wt1 interaction with actin as both Wt1 þ / þ and Wt1À/À isoforms co-precipitated with actin ( Figure 1d, lanes 4-5) . The N-terminal domain failed to precipitate actin (lane 2), whereas a zinc finger containing C-terminal construct succeeded (lane 3). Taken together, these results confirm that WT1 and actin can be found together in protein complexes in the live cell and that their interaction is mediated through the Wt1 zinc finger domain.
What functional features of Wt1 could be affected by actin binding? Actin was shown to be actively exported from the nucleus and implicated in RNA export. Wt1 was shown to be able to bind to RNA and to shuttle between the nucleus and the cytoplasm (Niksic et al., 2004) . We checked whether these properties of both proteins could be linked. Actin filaments, together with associated proteins, have an extremely important role in the cell, and equilibrium of actin structural state can be used as a regulatory point for its functions. We examined whether the nucleo-cytoplasmic shuttling of WT1 protein depended on the actin polymerization state. We tested the shuttling of endogenous Wt1 in the presence of actin depolymerizing drugs Cytochalasin B and Cytochalasin D (CD) (Figure 2A) , as well as Latrinculin B using M15 and HeLa cells. All three agents abolished WT1 shuttling, suggesting an actindependent mechanism for the process. This effect was not a result of drug toxicity as it was reversible (Wt1 resumed shuttling after CD was removed) (Figure 2Ac ). To determine specificity of the effect, we transfected cells with various constructs, including major Wt1 isoforms (Ladomery et al., 1999) . These constructs expressed the RNA-binding proteins GFP-hnRNP A1 (Figure 2Ba ) or GFP-SF2 ( Figure 2Bb) ; the Wt1 isoforms T7Wt1À/À and T7Wt1 þ / þ ( Figure 2Bc) ; and the Wt1 zinc finger domain, T7Wt1-ZF. We fused transfected and nontransfected cells and observed the tagged proteins shuttle in the presence or absence of actin-depolymerizing drugs. Shuttling of hRNP A1 and SF2 was not affected by actin perturbation. Thus, disruption of T7Wt1 shuttling under CD treatment (Figure 2Bc ) was Wt1 specific and was not dependent on the presence of exon 5 or KTS insert, as both Wt1À/À and Wt1 þ / þ behaved in a similar manner ( Figure 2C ). We could not quantitatively assess shuttling of the zinc finger domain of Wt1 as our construct lacks part of the NES (Vajjhala et al., 2003) and shuttles very poorly. It has been suggested before that actin is involved in the cytoplasmic transport of mRNAs; however, evidence obtained so far regarding its role in the nucleo-cytoplasmic shuttling of proteins and RNAs is controversial. Our data show for the first time, actin involvement in the nucleo-cytoplasmic transport of proteins and suggest a novel possible regulation of WT1 functions through actin recruitment.
Another pivotal function of actin is the maintenance of cell compartmentalization, including the positioning of messenger RNAs in the cytoplasm. A large fraction of mRNAs and polysomes (about 15-30%) are cytoskeleton associated (Jansen, 1999) . This association is at least partially actin dependent. Treatment of cells before polysome extraction with the microfilament-disrupting drug cytochalasin resulted in a loss of polysomes and mRNA from the cytoskeletal fraction. It has been recently discovered that Wt1 can bind mRNA in vivo and is found on actively transcribing polysomes (Niksic et al., 2004) . We explored the influence of actin polymerization state on the association of Wt1 with polysome populations. The M15 kidney cell line was treated with the actin depolymerization drug CD, followed by polysome fractionation of the cytoplasm. We found that most of the cytoplasmic Wt1 localized on cytoskeleton-bound polysomes (Figure 3a, lanes 3-4) and actin depolymerization partially shifted it towards the free polysome fractions (data not shown). The presence of Wt1 on cytoskeleton-bound polysomes, and thus its possible presence in large RNA-protein complexes, could partially explain the increase in the abundance of Wt1 in cytoplasmic immunoprecipitates in Figure 1b under urea treatment that could have denatured some of the high molecular complexes and facilitate the break-up of cytoskeleton structures containing Wt1, providing more protein for subsequent IP. These data suggest cytoskeleton-dependent regulation of WT1 binding to RNA. This hypothesis is further examined below. Sucrose gradient polysome fractionation and subsequent immunoblotting of the obtained fractions demonstrated that Wt1 was shifted off polysomes (fractions 3-5) towards lighter polysome fractions, monosomes and free RNPs (fractions 6-9) on actin filament disruption (Figure 3b ), in accordance with the role suggested above for the cytoskeleton in Wt1 functions. The distribution of S6 ribosomal protein was unaltered (data not shown). These findings suggest that actin may participate in the loading of Wt1 on the polysomes; however, it does not clarify whether both proteins are present in the same RNA containing complexes. 
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It has previously been established that both Wt1 (Ladomery et al., 2003; Niksic et al., 2004) and actin could bind mRNAs in vivo. We checked whether actin state could influence Wt1 RNA-and DNA-binding properties in vitro and in vivo. The zinc finger domain is responsible for the nucleic acid-binding properties of Wt1 (Caricasole et al., 1996) and for actin binding. Changes in the dynamic state of actin could affect Wt1 Figure 2 Depolymerization of actin abolishes Wt1 nucleo-cytoplasmic shuttling. (A) Heterokaryon formation assay. Nucleocytoplasmic shuttling of endogenous WT1 protein was assayed by the heterokaryon formation assay using WT1-expressing mouse M15 cells and non-expressing HeLa cells loaded with live cell dye (Molecular Probes) (green). M15 cells on coverslips were co-incubated with an excess of HeLa cells for 2 h in the presence of 50 mg/ml of cycloheximide (Sigma-Aldrich). One hour before fusion, cells were incubated in DMEM containing 100 mg/ml cycloheximide and 100 ng/ml Cytochalasin D (CD) (panel Ad-f) or corresponding dilution of DMSO (panel Aa-c). For the fusion, cells were treated with 50% PEG for 2 min, followed by washing in PBS. Shuttling was performed in fresh DMEM containing 100 mg/ml of cycloheximide in the presence (panel Ad-f) or absence (panel Aa-c) of 200 ng/ml CD for 1 h. Cells were immunostained with anti-Wt1 C19 antibody (Niksic et al., 2004) (red) . DAPI staining (blue) was used to detect heterochromatin condensates as a marker of mouse M15 cells. At least 50 heterokaryons were analysed for each experiment. Arrows show recipient nuclei. (B) Transfection of shuttling proteins. 3T3 mouse fibroblasts were transfected with constructs expressing GFPhnRNP A1 (panel Ba), GFP-SF2 (gift from H Caseres) (panel Bb) and T7Wt1À/À (Niksic et al., 2004) and fused with non-transfected HeLa cells. Alternatively, HeLa cells transfected with T7Wt1 þ / þ (panel Bc) were fused with mouse fibroblasts 3T3. A heterokaryon assay was carried out as described in Figure 5 for 1 h in 100 mg/ml of cycloheximide in the presence or absence of 200 ng/ml CD in culture media. The cells were stained for the Tag epitopes (GFP-green, T7-red) to trace the shuttling proteins and with anti-cytokeratin antibody (red panel Ba and b) (stains only epithelial HeLa and fused HeLa-3T3 but not fibroblastic non-fused 3T3s) or FITC-Phalloidin (panel Bc) to detect fused cells. DAPI staining (blue) was used to detect heterochromatin condensates as a marker of mouse 3T3 cells. Arrows show the nuclei in heterokaryons that received shuttling proteins. (C) Cell count. At least 120 heterokaryons were analysed for each experiment. Almost all (93%) of heterokaryons expressing GFP-hnRNP A1 (n ¼ 172) and most expressing GFP-SF2 (70%, n ¼ 120) had shuttling protein, whereas T7Wt1À/À and T7Wt1 þ / þ both lost their ability to shuttle almost completely (7%, n ¼ 140 and 6%, n ¼ 100, respectively). DMEM, Dulbecco's modified Eagle's medium; PBS, phosphatebuffered saline; DAPI, 4 0 ,6-diamidino-2-phenylindole; GFP, green fluorescent protein; FITC, fluorescein isothiocyanate. Cytoplasmic extracts from cells treated (E) or untreated (D) with 0.1 mg/ml Cytochalasin D were prepared in buffer A (20 mM Tris pH 7.5, 100 mM KCl, 5 mM MgCl2, 0.3% NP-40, RNAse, protease inhibitors). The extracts were layered onto 10 ml linear 10-50% sucrose gradients containing 20 mM Tris, pH 7.5, 5 mM MgCl 2 , 100 mM KCl and centrifuged at 37 000 r.p.m. for 2 h. The gradients were fractionated using a Pharmacia Superfrac fraction collector and the absorbance of cytosolic RNA at 254 nm was recorded. Proteins in fractions were precipitated by trichloroacetic acid (TCA), resuspended in the loading buffer and analysed by western blot using antiWt1 rabbit polyclonal C19 antibody (Santa-Cruz).
functions connected with its DNA/RNA binding. We performed EMSA assays (Discenza et al., 1997) with the DNA oligonucleotide representing the Wt1 binding site from the amphiregulin promoter (Lee et al., 1999) 5 0 CCCGGCCGTGGGTGGA3 0 . A 32p-labelled probe was incubated with M15 nuclear extracts treated and non-treated with Jasplakinolide or CD and analysed by EMSA. The Wt1-specific bands (marked with arrows) were slightly reduced by actin depolymerization (Figure 4a , lane 5), but were very much reduced in nuclear extracts from cells treated with the drug Jasplakinolide (Molecular Probes Europe BV, London, UK) shifting the equilibrium towards filamentous actin (Sheikh et al., 1997) (Figure 4a, lane 6) or by anti-actin antibody (lane 4). This suggests that monomeric actin may be an important partner in Wt1 DNA-binding complexes, and that forced polymerization of actin in nuclear extracts prevents Wt1 from binding to its target sites. To assess the influence of actin equilibrium on the expression of Wt1 target genes, we treated M15 kidney cells for 24 h with 50 ng/ml CD, 10 mM Jasplakinolide or a corresponding dilution of dimethyl sulphoxide. RNA was extracted and the mRNA expression of amphiregulin was studied using real-time reverse transcriptase-PCR (Figure 4b ). In accordance with the idea that polymerized actin could compete for Wt1 and recruit it from its DNA-binding sites, the expression of amphiregulin under Jasplakinolide treatment decreased drastically. Conversely, there was an increase in amphiregulin expression on actin partial depolymerization that provides more monomeric actin for nuclear complexes. This suggests that monomeric actin could help in facilitating Wt1-driven transcription. Neither effects resulted from drug toxicity and were specific as the levels of b-actin mRNA remained almost unaltered. Also the expression of Ptch1 that was not reported to be a direct Wt1 transcription target was reciprocal-that is, increased on actin force polymerization (Figure 4b) . To test the influence of actin polymeric state on Wt1 RNA-binding properties, M15 cells were treated for 2 h with CD, Jasplakinolide or dimethyl sulphoxide alone. Cell cytoplasm extraction and IP with anti-Wt1 C19 antibody was performed as described in Figure 1 , but in the presence of RNAse inhibitors instead of RNAseA. Precipitated complexes were washed and RNA was isolated and used for reverse transcriptase-PCR analysis. The results showed that disruption of actin filaments reduced Wt1 RNA-binding efficiency but did not cancel it completely. The total amount of RNA precipitated with anti-Wt1 antibodies (10 mg) from cell extracts with depolymerized actin was about four times lower than that from normal cells (Figure 4c ). However, forced actin polymerization slightly increased the amount of immunoprecipitated RNA (Figure 4d) .
Recently, we have obtained data showing that WT1 can bind to specific mRNAs, including amphiregulin mRNA (Dudnakova T, unpublished data). As shown in Figure 4d , the amount of amphiregulin mRNA in Wt1-immunoprecipitated complexes was also decreased on CD treatment.
We speculate that monomeric actin could be a Wt1 cofactor in the nucleus, and that polymerized filamentous actin could facilitate Wt1 RNA binding, promoting Wt1 cytoplasmic functions (Figure 4d ). This would agree with the data described above regarding the Wt1 localization on cytoskeleton-bound polysomes and requirement of intact actin filaments for Wt1 polysome loading.
The polymerization state of actin is immensely important for cell morphology and movement, cell adhesion and proliferation, differential distribution of RNAs, as well as for the transcription of some predominantly cytoskeleton genes, including actin itself. Alterations of actin polymerization drive invasive morphological changes in malignant cells including modulation of adhesion complexes and, associated with them, microfilaments (Gimona, 2008) . Actin remodelling could be the result of activation of oncogenic signalling pathways, or misexpression of some actin-binding proteins (Rao and Li, 2004) . Wt1 was named as one of the proteins implicated in actin cytoskeletal changes in cancer cells (Jomgeow et al., 2006) and cultured podocytes (Viney et al., 2007) . In this study, we show that actin remodelling could have a direct influence on the location and regulation of Wt1 functions in the cell. Predominantly, cytoplasmic localization of Wt1 in cancer cells could be connected directly to changes in actin equilibrium. Direct Wt1 actin interaction through the zinc finger domain could represent a sensitive regulatory loop, the disturbance of which could facilitate malignant transformations. It is essential that we could confirm this interaction both in vitro and in vivo using short-range cross-linking. The importance of the balanced Wt1-actin connections was supported by the observations that perturbations of actin polymerization state disturbed WT1 nucleo-cytoplasmic shuttling, displaced WT1 from the polysomes and influenced Wt1 DNA-and RNAbinding properties. Physical interaction of WT1 with actin supports the hypothesis of WT1 involvement in RNA metabolism. We speculate that WT1 might be a specific adaptor protein that links a specific subset of mRNAs to actin for transporting to the target location. Actin could also have the role of a cytoplasmic anchor for Wt1, and the Wt1-actin functional interaction could be studied further as a potential novel regulation loop involved in the malignant transformation of the cell when Wt1 becomes predominantly cytoplasmic.
